Exdensur
depemokimab
Listed by GlaxoSmithKline LLC
- Strength
- 100 mg/mL
- Form
- Injection, Solution
- Route
- Subcutaneous
What it contains
- Depemokimab 100 mg/mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Approval route | BLA — biologic licence |
| NDC code | 0173-0927 |
| FDA application | BLA761458 |
| RxNorm concept | 2729271 |
| Package sizes listed | 2 |
| Marketed since | December 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.